Concepedia

Publication | Open Access

First clinical study using HCV protease inhibitor danoprevir to treat COVID-19 patients

DOIFull Paper Access

89

Citations

13

References

2020

Year

Hongyi Chen, Zhicheng Zhang, Li Wang, Zhihua Huang, Fanghua Gong, Xiaodong Li, Yahong Chen, Jinzi J. Wu
Medicine

Abstract

Our findings suggest that repurposing danoprevir for COVID-19 is a promising therapeutic option.

References

YearCitations

Page 1